Pular para o conteúdo principal
Ranking Invest

EW - Edwards Lifesciences Corporation

Segmento: HealthcareEdwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Análise Ranking Invest

Valuation estimado
$ 18.06 Bi
Valor de Mercado
$ 48.63 Bi
Sobrepreço (AV)+169.2%
IVR
0.37A companhia vale 0,37 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.15O valuation alternativo equivale a 15% do valor de mercado da companhia.
MLL
0.15O lucro líquido dos controladores em 16 trimestres equivale a 15% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 10.51 Bi

Dívida Líquida

-$ 2.31 Bi

L4T

$ 1.00 Bi

MM4T

15.39%

Indicadores Básicos

ROE

9.56%

Índices de Previsibilidade

Receita Líquida

C0.05

Lucro

B0.15

Margem

B0.17

Índices de Tendência

Receita Líquida

C7.56

Lucro

F-5.96

Margem

F-7.51

Índices de Endividamento

DIV/PAT

-0.22

DIV/L4T

-2.30

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.